disopyramide has been researched along with Coronary Heart Disease in 54 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of intravenously administered disopyramide phosphate were evaluated in seven patients with refractory ventricular tachycardia." | 9.04 | Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. ( Mason, DT; Miller, RR; Vera, Z; Vismara, LA, 1977) |
| "Twenty-six patients with clinically significant ventricular arrhythmias were randomly assigned to treatment with either intravenous disopyramide or lidocaine; crossover to the other agent was permitted in nine cases of primary drug failure." | 9.04 | Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial. ( Fozzard, HA; Rawling, DA; Sbarbaro, JA, 1979) |
| "The response of arrhythmias to oral disopyramide in relation to its serum levels has been documented." | 9.04 | Disopyramide: serum level and arrhythmia conversion. ( Niarchos, AP, 1976) |
| "Disopyramide is an effective class I antiarrhythmic drug and widely used for the treatment of arrhythmias, but it has anticholinergic side effects." | 7.69 | Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias. ( Eto, K; Hashimoto, K; Nakamura, M; Xue, Y, 1996) |
| "Intraindividual comparison of the acute response to intravenous quinidine and to intravenous disopyramide was performed in 27 patients with sustained ventricular tachycardia (VT) who underwent serial electrophysiological studies." | 7.67 | Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia. ( Brachmann, J; Kübler, W; Lengfelder, W; Rizos, I; Schmitt, C; Senges, J; von Olshausen, K, 1987) |
| "A patient with ischemic cardiomyopathy and congestive heart failure was treated with disopyramide phosphate for ventricular arrhythmias." | 7.66 | Disopyramide-induced ventricular tachycardia. ( Gantz, KB; Lo, KS; Lucchesi, BR; Pitt, B; Stetson, PL, 1980) |
| "The effect of disopyramide phosphate (DP) infusion (1 mg/Kg and 2 mg/Kg BW) on ventricular fibrillation threshold (VFT) was studied in anesthetized dogs." | 7.66 | The effect of disopyramide phosphate on ventricular fibrillation threshold of normal and ischemic ventricles. ( Dohi, Y; Tajima, T, 1983) |
| "The effects of intravenous doses of Org 6001 and disopyramide (10 mg/kg) known to confer protection against early postligation-induced arrhythmias in the anaesthetized rat when given prophylactically, were assessed following postligation administration." | 7.66 | The effects of postligation administration of ORG 6001 and disopyramide on early ischaemia-induced arrhythmias in the anaesthetized rat. ( Marshall, RJ; Muir, AW; Winslow, E, 1982) |
| "Disopyramide, a new anti-arrhythmic drug, has been assessed in twenty-one episodes of cardiac arrhythmia secondary to acute ischaemic heart disease which failed to respond to more conventional suppressive therapy with lignocaine and other standard drugs." | 7.65 | The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease. ( Sandler, G, 1977) |
| "Moricizine (moracizine) is a new class I antiarrythmic drug which is undergoing a large scale clinical trial at present." | 5.28 | The effect of pretreatment with moricizine on early arrhythmia resulting from myocardial ischemia in rats. ( Hashimoto, K; He, ZS; Komori, S; Tamura, K, 1992) |
| " 3 Mean elimination half-life (6." | 5.26 | Disopyramide pharmacokinetics during recovery from myocardial infarction. ( Bryson, SM; Cairns, CJ; Whiting, B, 1982) |
| "The effects of intravenously administered disopyramide phosphate were evaluated in seven patients with refractory ventricular tachycardia." | 5.04 | Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. ( Mason, DT; Miller, RR; Vera, Z; Vismara, LA, 1977) |
| "Twenty-six patients with clinically significant ventricular arrhythmias were randomly assigned to treatment with either intravenous disopyramide or lidocaine; crossover to the other agent was permitted in nine cases of primary drug failure." | 5.04 | Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial. ( Fozzard, HA; Rawling, DA; Sbarbaro, JA, 1979) |
| "The response of arrhythmias to oral disopyramide in relation to its serum levels has been documented." | 5.04 | Disopyramide: serum level and arrhythmia conversion. ( Niarchos, AP, 1976) |
| "Disopyramide is an effective class I antiarrhythmic drug and widely used for the treatment of arrhythmias, but it has anticholinergic side effects." | 3.69 | Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias. ( Eto, K; Hashimoto, K; Nakamura, M; Xue, Y, 1996) |
| "Though the efficacies of procainamide and disopyramide in treating arrhythmias are well established, their precise mechanisms of antiarrhythmic action remain unclear." | 3.67 | Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart. ( Kobayashi, A; Watanabe, H; Yamazaki, N, 1988) |
| "Intraindividual comparison of the acute response to intravenous quinidine and to intravenous disopyramide was performed in 27 patients with sustained ventricular tachycardia (VT) who underwent serial electrophysiological studies." | 3.67 | Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia. ( Brachmann, J; Kübler, W; Lengfelder, W; Rizos, I; Schmitt, C; Senges, J; von Olshausen, K, 1987) |
| "A patient with ischemic cardiomyopathy and congestive heart failure was treated with disopyramide phosphate for ventricular arrhythmias." | 3.66 | Disopyramide-induced ventricular tachycardia. ( Gantz, KB; Lo, KS; Lucchesi, BR; Pitt, B; Stetson, PL, 1980) |
| "The effect of disopyramide phosphate (DP) infusion (1 mg/Kg and 2 mg/Kg BW) on ventricular fibrillation threshold (VFT) was studied in anesthetized dogs." | 3.66 | The effect of disopyramide phosphate on ventricular fibrillation threshold of normal and ischemic ventricles. ( Dohi, Y; Tajima, T, 1983) |
| "The effects of intravenous doses of Org 6001 and disopyramide (10 mg/kg) known to confer protection against early postligation-induced arrhythmias in the anaesthetized rat when given prophylactically, were assessed following postligation administration." | 3.66 | The effects of postligation administration of ORG 6001 and disopyramide on early ischaemia-induced arrhythmias in the anaesthetized rat. ( Marshall, RJ; Muir, AW; Winslow, E, 1982) |
| "Disopyramide, a new anti-arrhythmic drug, has been assessed in twenty-one episodes of cardiac arrhythmia secondary to acute ischaemic heart disease which failed to respond to more conventional suppressive therapy with lignocaine and other standard drugs." | 3.65 | The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease. ( Sandler, G, 1977) |
| "Moricizine (moracizine) is a new class I antiarrythmic drug which is undergoing a large scale clinical trial at present." | 1.28 | The effect of pretreatment with moricizine on early arrhythmia resulting from myocardial ischemia in rats. ( Hashimoto, K; He, ZS; Komori, S; Tamura, K, 1992) |
| " However, the lower, sustained dosage of disopyramide was associated with a lower average serum level of 2." | 1.27 | Effects of disopyramide on left ventricular function: assessment by radionuclide cineangiography. ( Bates, R; Dibianco, R; Fletcher, RD; Gottdiener, JS; Sauerbrunn, BJ, 1983) |
| "After treatment of ischemia and/or failure, specific antiarrhythmic agents, conventional and investigational, alone or in combination, are systematically selected." | 1.26 | Ventricular ectopy: etiology, evaluation, and therapy. ( Reid, PR; Vlay, SC, 1982) |
| " 3 Mean elimination half-life (6." | 1.26 | Disopyramide pharmacokinetics during recovery from myocardial infarction. ( Bryson, SM; Cairns, CJ; Whiting, B, 1982) |
| "The serum concentration/time profiles resulting from two oral disopyramide dosage regimes were studied in ten patients with ischaemic heart disease." | 1.26 | Oral disopyramide dosage regimes in ischaemic heart disease. ( Bryson, SM; Fotheringham, GH; Struthers, MG; Whiting, B, 1982) |
| "Disopyramide (1." | 1.26 | Effects of intravenous disopyramide on myocardial function in patients with different degrees of cardiac failure. ( Chiariello, M; Condorelli, M; Ferro, G; Santinelli, V; Spinelli, L; Tari, MG, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 45 (83.33) | 18.7374 |
| 1990's | 9 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vlay, SC | 1 |
| Reid, PR | 1 |
| Lo, KS | 1 |
| Gantz, KB | 1 |
| Stetson, PL | 1 |
| Lucchesi, BR | 1 |
| Pitt, B | 1 |
| Zhivoderov, VM | 1 |
| Zakharov, VN | 1 |
| Doshchitsin, VL | 1 |
| Aksenova, TN | 1 |
| Andriukova, EI | 1 |
| Lüderitz, B | 1 |
| Vaughan Williams, EM | 1 |
| Gottdiener, JS | 1 |
| Dibianco, R | 1 |
| Bates, R | 1 |
| Sauerbrunn, BJ | 1 |
| Fletcher, RD | 1 |
| Tajima, T | 1 |
| Dohi, Y | 1 |
| Milne, JR | 1 |
| Hellestrand, KJ | 1 |
| Bexton, RS | 1 |
| Burnett, PJ | 1 |
| Debbas, NM | 1 |
| Camm, AJ | 1 |
| Wester, HA | 1 |
| Mouselimis, N | 1 |
| Ferro, G | 3 |
| Chiariello, M | 3 |
| Tari, MG | 3 |
| Vigorito, C | 1 |
| Ungaro, B | 1 |
| Condorelli, M | 3 |
| Breithardt, G | 1 |
| Seipel, L | 1 |
| Abendroth, RR | 1 |
| Loogen, F | 1 |
| Bryson, SM | 2 |
| Cairns, CJ | 1 |
| Whiting, B | 2 |
| Fotheringham, GH | 1 |
| Struthers, MG | 1 |
| Han, P | 1 |
| Boatwright, C | 1 |
| Ardlie, NG | 1 |
| Marshall, RJ | 1 |
| Muir, AW | 1 |
| Winslow, E | 1 |
| Santinelli, V | 2 |
| Spinelli, L | 1 |
| Kötter, V | 1 |
| Linderer, T | 1 |
| Schröder, R | 1 |
| Komori, S | 3 |
| Sano, S | 1 |
| Li, BH | 1 |
| Matsumura, K | 1 |
| Naitoh, A | 1 |
| Mochizuki, S | 1 |
| Ishihara, T | 1 |
| Watanabe, A | 1 |
| Umetani, K | 1 |
| Ijiri, H | 1 |
| Sawanobori, T | 1 |
| Tamura, K | 2 |
| Kane, KA | 1 |
| Parratt, JR | 1 |
| Nakamura, M | 1 |
| Xue, Y | 1 |
| Eto, K | 1 |
| Hashimoto, K | 2 |
| Ruffy, R | 1 |
| Zipes, DP | 1 |
| Vismara, LA | 1 |
| Vera, Z | 1 |
| Miller, RR | 1 |
| Mason, DT | 2 |
| Levites, R | 1 |
| Anderson, GJ | 1 |
| Sbarbaro, JA | 1 |
| Rawling, DA | 1 |
| Fozzard, HA | 1 |
| Stanislao, M | 1 |
| Niarchos, AP | 1 |
| Sandler, G | 1 |
| Marrott, PK | 1 |
| Ruttley, MS | 1 |
| Winterbottam, JT | 1 |
| Muir, JR | 1 |
| Befeler, B | 1 |
| Castellanos, A | 1 |
| Wells, DE | 1 |
| Vagueiro, MC | 1 |
| Yeh, BK | 1 |
| Casedevant, B | 1 |
| Sabaut, D | 1 |
| Clementy, J | 1 |
| Dallocchio, M | 1 |
| He, ZS | 1 |
| Korkushko, OV | 1 |
| Shatilo, VB | 1 |
| Plachinda, IuI | 1 |
| Fujimoto, Y | 1 |
| Fukuki, M | 1 |
| Hirokane, Y | 1 |
| Kotake, H | 1 |
| Mashiba, H | 1 |
| Dabrowski, A | 1 |
| Ostrowska, B | 1 |
| Bacior, B | 1 |
| Fryśna-Dmuchowska, B | 1 |
| Kargul, W | 1 |
| Król, J | 1 |
| Królikowski, Z | 1 |
| Luczak, D | 1 |
| Malczewska, B | 1 |
| Nessler, J | 1 |
| Oźarek-Medyńska, T | 1 |
| Krynicki, M | 1 |
| Polubiec, A | 1 |
| Mehlsen, J | 1 |
| Bonde, J | 4 |
| Rehling, M | 1 |
| Tangø, M | 1 |
| Trap-Jensen, J | 2 |
| Endresen, K | 1 |
| Amlie, JP | 1 |
| Forfang, K | 1 |
| Kirichenko, LL | 2 |
| Masenko, VP | 2 |
| Gorshkov, VA | 2 |
| Narynski, AK | 1 |
| Kurakina, TI | 3 |
| Morozova, LM | 1 |
| Mamaev, VI | 1 |
| Tanabe, T | 1 |
| Yoshikawa, H | 1 |
| Tagawa, R | 1 |
| Furuya, H | 1 |
| Ide, M | 1 |
| Goto, Y | 1 |
| Liusov, VA | 1 |
| Dudaev, VA | 1 |
| Borodkin, VV | 1 |
| Rudakov, AV | 1 |
| Nikitin, AE | 1 |
| Sherashov, VS | 1 |
| Solov'eva, FV | 1 |
| Goedel-Meinen, L | 1 |
| Hofmann, M | 1 |
| Schmidt, G | 1 |
| Barthel, P | 1 |
| Baedeker, W | 1 |
| Blömer, H | 1 |
| Kobayashi, A | 1 |
| Watanabe, H | 1 |
| Yamazaki, N | 1 |
| Kurbanov, RD | 1 |
| Kiiakbaev, GK | 1 |
| Pedersen-Bjergaard, O | 1 |
| Lindeneg, O | 1 |
| Svendsen, TL | 3 |
| Enk, B | 1 |
| Fridberg, M | 1 |
| Rizos, I | 1 |
| Brachmann, J | 1 |
| Lengfelder, W | 1 |
| Schmitt, C | 1 |
| von Olshausen, K | 1 |
| Kübler, W | 1 |
| Senges, J | 1 |
| Pedersen, LE | 2 |
| Angelo, HR | 2 |
| Kampmann, JP | 3 |
| Graudal, NA | 1 |
| Backer, NV | 1 |
| Hansen, JE | 1 |
| Gardner, MJ | 1 |
| McCarthy, DM | 1 |
| Josephson, ME | 1 |
| Härtel, G | 1 |
| Bødtker, S | 1 |
| Pellegrino, L | 1 |
| Prencipe, D | 1 |
2 reviews available for disopyramide and Coronary Heart Disease
| Article | Year |
|---|---|
Disopyramide.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Electrocardiograph | 1984 |
[Disopyramide: its mechanisms of action and clinical use].
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Drug Evaluation; D | 1985 |
9 trials available for disopyramide and Coronary Heart Disease
| Article | Year |
|---|---|
[The effect of anti-arrhythmic drugs on myocardial function (author's transl)].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Disease; Depression, Chemical; Disopyramide; Echocardi | 1982 |
Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Clinical Trials as Topic; Coronary | 1980 |
Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia.
Topics: Aged; Clinical Trials as Topic; Coronary Disease; Disopyramide; Drug Evaluation; Heart Failure; Huma | 1977 |
Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial.
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Humans; Injections | 1979 |
Disopyramide: serum level and arrhythmia conversion.
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Biopharmaceutics; Blood Pressure; Clinical Trials | 1976 |
Effects of disopyramide on repolarisation and intraventricular conduction in man.
Topics: Action Potentials; Adult; Cardiac Complexes, Premature; Clinical Trials as Topic; Coronary Disease; | 1988 |
[Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Clinical Trials as Topic; Coronary Disease; Disopyr | 1988 |
[Disopyramide and lignocaine in the treatment of ventricular arrhythmia in patients with acute ischemic heart disease].
Topics: Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Disopyramide; Double-Blind M | 1986 |
Haemodynamic effects and kinetics of concomitant intravenous disopyramide and atenolol in patients with ischaemic heart disease.
Topics: Aged; Atenolol; Coronary Disease; Disopyramide; Drug Therapy, Combination; Female; Heart Rate; Hemod | 1986 |
43 other studies available for disopyramide and Coronary Heart Disease
| Article | Year |
|---|---|
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhyth | 1982 |
Disopyramide-induced ventricular tachycardia.
Topics: Alcoholism; Cardiac Complexes, Premature; Cardiomyopathies; Coronary Disease; Disopyramide; Heart Fa | 1980 |
[Anti-arrhythmic effectiveness of ethmozine, cordaron and rhythmodan in treating ischemic heart disease].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Cardiac Complexes | 1981 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Comp | 1983 |
Effects of disopyramide on left ventricular function: assessment by radionuclide cineangiography.
Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Coronary Disease; Disopyramide; Heart; Heart Ventricles; | 1983 |
The effect of disopyramide phosphate on ventricular fibrillation threshold of normal and ischemic ventricles.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Coronary Disease; Disopyramide; Dogs; Electric Stim | 1983 |
Class 1 antiarrhythmic drugs--characteristic electrocardiographic differences when assessed by atrial and ventricular pacing.
Topics: Action Potentials; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Disease; Disop | 1984 |
Intropic effects of several antiarrhythmic drugs.
Topics: Ajmaline; Anti-Arrhythmia Agents; Aprindine; Blood Pressure; Bunaftine; Coronary Disease; Disopyrami | 1983 |
Disopyramide pharmacokinetics during recovery from myocardial infarction.
Topics: Adult; Aged; Biological Availability; Coronary Disease; Disopyramide; Female; Half-Life; Humans; Kin | 1982 |
Oral disopyramide dosage regimes in ischaemic heart disease.
Topics: Administration, Oral; Adult; Aged; Coronary Disease; Disopyramide; Drug Administration Schedule; Fem | 1982 |
Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide.
Topics: Adenosine Triphosphate; Arachidonic Acids; Blood Platelets; Coronary Disease; Disopyramide; Humans; | 1982 |
The effects of postligation administration of ORG 6001 and disopyramide on early ischaemia-induced arrhythmias in the anaesthetized rat.
Topics: Androstanols; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cor | 1982 |
Effects of intravenous disopyramide on myocardial function in patients with different degrees of cardiac failure.
Topics: Arrhythmias, Cardiac; Coronary Disease; Depression, Chemical; Disopyramide; Humans; Injections, Intr | 1980 |
Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine.
Topics: Adult; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Disease; Diastole; Disopyramid | 1980 |
Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Complexes, Premature; Coronary Disease; Dis | 1995 |
Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
Topics: Amino Alcohols; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Dise | 1994 |
Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Digitali | 1996 |
Preventing ventricular arrhythmias in ischemic heart disease.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Humans; Lidocaine; Nitroglyce | 1979 |
Electrophysiological effects of disopyramide phosphate during experimental myocardial ischemia.
Topics: Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Coronary Disease; Coronary Vessels; Diso | 1979 |
[Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
Topics: Adult; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Electrocardiography; Female; Heart Rate | 1979 |
Disopyramide: a new agent for effective therapy of ventricular dysrhythmias.
Topics: Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Electrocardiography; Humans; Pyridines | 1978 |
The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
Topics: Acute Disease; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Humans; Pyridines | 1977 |
A study of the acute electrophysiological and cardiovascular action of disopyramide in man.
Topics: Adult; Atrioventricular Node; Blood Pressure; Coronary Disease; Disopyramide; Female; Heart Conducti | 1976 |
Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate.
Topics: Adult; Age Factors; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Bundle-Branch Block; Coronary D | 1975 |
[Letter: Syncopes through the inversion of points in connection with the absorption of disopyramide].
Topics: Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Female; Humans; Hypertension; Hypokalemia; Mid | 1975 |
The effect of pretreatment with moricizine on early arrhythmia resulting from myocardial ischemia in rats.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Hemodynamics; Male; Mexiletine; Moric | 1992 |
[Significance of spectral analysis of rhythmograms in the selection of anti-arrhythmia agents for aged patients with extrasystolic arrhythmia].
Topics: Aged; Cardiac Complexes, Premature; Coronary Disease; Disopyramide; Electrocardiography; Heart Rate; | 1990 |
Clinical study on coupling interval of ventricular premature contraction in patients with organic heart disease.
Topics: Cardiac Complexes, Premature; Coronary Disease; Disopyramide; Electrocardiography, Ambulatory; Femal | 1991 |
[Effect of amiodarone and disopyramide on the results of electrocardiographic exercise stress testing in patients with coronary disease].
Topics: Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Electrocardiography; Exercise Test | 1990 |
Results of the treatment of cardiac arrhythmias with Palpitin.
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Female; Heart Failure; Humans; Hy | 1990 |
A comparison of systolic time intervals measured by impedance cardiography and carotid pulse tracing.
Topics: Cardiac Output; Cardiography, Impedance; Carotid Arteries; Coronary Disease; Disopyramide; Epinephri | 1990 |
Platelet aggregation and prostaglandin metabolites in the blood of patients with ischaemic heart disease during antiarrhythmic treatment.
Topics: Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Coronary Disease; Disopyramide; Female; Humans | 1989 |
Evaluation of antiarrhythmic drug efficacy using holter electrocardiographic technique.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, | 1985 |
[Changes in thrombocyte-vascular hemostasis and cyclic nucleotide levels after anti-arrhythmia therapy in patients with ischemic heart disease].
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Female; Humans; Male; Mexiletine; | 1989 |
[Effect of palpitin on plasma, thrombocytes and vascular hemostasis].
Topics: Adolescent; Adult; Aged; Blood Platelets; Blood Vessels; Coronary Disease; Disopyramide; Drug Evalua | 1987 |
[Clinical effectiveness of palpitin in treating heart rhythm disorders in ischemic heart disease patients].
Topics: Aged; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Drug Evaluation; Electrocardiography; Fe | 1987 |
Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart.
Topics: Acyl Coenzyme A; Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Disopyramide; Dogs; Fat | 1988 |
[Clinico-pharmacological interactions of digoxin with ethmozine, disopyramide and amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Digoxin; Disopyramide; Drug Synergism; Drug Ther | 1988 |
Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Coronary Disease; Disopyramide; Electroc | 1987 |
Quantitative and qualitative binding characteristics of disopyramide in serum from patients with decreased renal and hepatic function.
Topics: Adult; Aged; Coronary Disease; Disopyramide; Female; Humans; Kidney Failure, Chronic; Liver Cirrhosi | 1987 |
Effect of myocardial ischemia and type I antiarrhythmic drug therapy on exercise QT intervals.
Topics: Anti-Arrhythmia Agents; Coronary Disease; Disopyramide; Electrocardiography; Exercise Test; Heart Co | 1985 |
Atenolol inhibits the elimination of disopyramide.
Topics: Adult; Aged; Atenolol; Coronary Disease; Dealkylation; Disopyramide; Female; Half-Life; Humans; Kine | 1985 |
[Disopyramide in the therapy and prevention of chronic atrial fibrillation. Study of 50 cases].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arteriosclerosis; Atrial Fibrillation; Coronary Disease; Disopy | 1973 |